About Palmtree Clinical Research, Inc.

Palmtree Clinical Research, Inc. (PCR, Inc.) was founded in 2010 to provide leadership in clinical research and to bring new medications, devices, diagnostic tools, and medical treatments to the Coachella Valley. Often, these medications and so forth are experimental and only available in universities, medical schools and leading medical centers in large urban cities. PCR, Inc. conducts clinical trials, scientific studies, and investigator-initiated research throughout the desert communities. In 2012, PCR, Inc. affiliated with Eisenhower Medical Center to provide research capabilities for its primary care staff and residency programs.

In 2014, PCR, Inc. relocated to larger facilities in Palm Springs, CA to fulfill its commitment to serve all communities throughout the valley. This commitment involves conducting clinical research with the goal of helping the people in the desert communities live longer, healthier lives. PCR, Inc. is the first independent community-based clinical research center and site management organization (SMO) in the desert. As such, PCR, Inc. works with physicians from the major medical centers, medical groups, and private practices in Palm Springs, Rancho Mirage, Palm Desert, and Riverside. Through clinical research, which involves people who volunteer to participate in studies, the research physicians can better understand how to diagnose, treat, and prevent diseases for their patients.

In 2018, PCR, Inc. relocated to an even larger research facility with private examination rooms, specimen processing areas, a comfortable waiting area, advanced medical equipment, and research offices. PCR also conducts trials and studies at medical centers and in physician’s clinics.

All research trials and studies are governed by regulations of the Food and Drug Administration (FDA) and of the Department of Health and Human Services (HHS). In addition PCR is overseen by independent ethics committees who are formally designated to approve, monitor, and review the research.

PCR, Inc. works with physicians experienced as Principal Investigators; the dedicated team is well qualified for research with over 30 years of combined experience. The clinical research staff is certified in Good Clinical Practices (GCP), International Conference of Harmonization (ICH), and Hazmat/IATA trained.

Qualified individuals who volunteer to participate in research are provided study related doctor visits, medical care, medication, and medical supplies free of any charges. Many studies also include compensation for study participation.

PCR, Inc. specializes in research Phases I-IV. Phase I trials test a small group of people to evaluate safety and determine side effects. Phase II studies focus on efficacy, safety, and dosage trials. Phase III studies are pivotal trials collecting information for FDA approval. Phase IV studies are post FDA-approved with large groups of people.



  • Cardiovascular – Acute Coronary Syndrome, Chronic Heart Failure, Hyperlipidemia, Coronary Artery Disease

  • Dermatology – Actinic Keratosis, Atopic Dermatitis, Psoriasis, Acne

  • Endocrinology – Diabetes, Obesity

  • Neuroscience – Huntington’s Disease

  • Gastrointestinal – Crohn’s Disease, Post-Operative Bowel Dysfunction

  • Infectious Disease – Chicken Pox Pediatric Vaccine, Hepatitis C, Hepatitis B, MMR, Pertussis, C-Difficile

  • HIV – Antiretroviral for both Naive and Experienced patients, Lipodystrophy

  • Nephrology – Anemia in Chronic Kidney Disease

  • Pulmonology – Chronic Obstructive Pulmonary Disease, Asthma, Pulmonary Arterial Hypertension

  • Oncology – Advanced Prostate Cancer, Colon Cancer